PharmaShots | Incisive News in 3 Shots

Subscribe Now

Cutaneous Squamous Cell Carcinoma

Merck's Keytruda (pembrolizumab) Receives the US FDA's Approval for Expanded Indication in Patients with Locally Advanced Cutaneous Squamous Cell Carcinoma

Merck's Keytruda (pembrolizumab) Receives the US FDA's Approval for Expanded Indication in Patients with Locally Advanced Cutaneou...

July 6, 2021

Merck's Keytruda (pembrolizumab) Receives the US FDA's Approval for Patients with Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma

Merck's Keytruda (pembrolizumab) Receives the US FDA's Approval for Patients with Recurrent or Metastatic Cutaneous Squamous Cell...

June 25, 2020

Sanofi and Regeneron Report Updated Results of Libtayo (cemiplimab-rwlc) in P-II EMPOWER-CSCC-1 Study for Locally Advanced and Metastatic Cutaneous Squamous Cell Carcinoma

Sanofi and Regeneron Report Updated Results of Libtayo (cemiplimab-rwlc) in P-II EMPOWER-CSCC-1 Study for Locally Advanced and Met...

May 17, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us